Contact
Header_1077x260px_About_Profil.jpg

Navigating Financial Incentives for SMEs in Europe's Biotech Landscape

First drug approved for NASH

BfArM speeds up the approval process for clinical trials in Germany

Correct interpretation of key CGM metrics

GLP-1 based drugs: Could Elon Musk’s weight loss weapon help us, too?

Profil's scientific publications in 2023 - an overview

A novel long-acting Amylin analogue for the management of obesity

Free Live Online Seminar: IMP management services for multi and single-center clinical trials in EU

CTR 536/2014: First approvals and our experience with CTIS (Part 3)

Profil World - The clinical diabetes research newsletter - Jun 2023